FIELD: pharmaceutics.
SUBSTANCE: invention relates to a method of producing 4(N)-substituted derivatives of compounds of formula (IB), where the method involves reacting a compound of formula (IB) with a chloroformate of formula (II) to obtain a compound of formula (IIIB), where R1 is selected from the structures specified in the claim; R2B represents fragments specified in the claim; R3B is hydrogen or halogen; and R4B is hydrogen; where the chloroformate of formula (II) is presented in the method in amount of 0.3 to 0.7 equivalents (by moles). Invention also relates to a method of producing a compound of formula (III), where the method involves reacting gemcitabine (I) with a chloroformate of formula (II) to obtain a compound of formula (III), where R1 is selected from the radicals indicated above. Invention also relates to a compound of formula (IV) and a method for production thereof, where n denotes 0.1 or 2, where the method involves obtaining compound (III) with a subsequent step of reacting compound (III) in N,N-diisopropylethylamine to form a compound of formula (IV). Invention also relates to a pharmaceutical composition based on a compound of formula (IV) and using a compound of formula (IV) or a pharmaceutical composition for treating malignant growths.
EFFECT: treatment of malignant neoplasms, which include breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer and bladder cancer.
13 cl, 7 tbl, 18 dwg
Title | Year | Author | Number |
---|---|---|---|
NEW TYPE OF CYTIDINE DERIVATIVES AND USE THEREOF | 2015 |
|
RU2684402C2 |
QUINAZOLINE DERIVATIVES | 2009 |
|
RU2506261C2 |
NEW SALICYLIC ACID DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALT, COMPOSITIONS AND METHOD FOR APPLICATION | 2013 |
|
RU2641903C2 |
N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, ITS PREPARATION METHOD AND ITS APPLICATION | 2018 |
|
RU2765785C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING CANCER | 2016 |
|
RU2736501C2 |
THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
Authors
Dates
2024-10-17—Published
2020-04-14—Filed